药物对比
Semaglutide vs Tolazamide
Semaglutide与Tolazamide治疗2型糖尿病对比：GLP-1受体激动剂与第一代磺脲类。比较A1c、减重、心血管获益与低血糖风险及较老药物。
此页面暂无可用的对比维度。
临床背景
This comparison is relevant when considering a modern GLP-1 agonist versus an older first-generation sulfonylurea for type 2 diabetes, often in cost or access-constrained settings.
结论
Semaglutide is generally preferred for broader metabolic and CV benefits, while Tolazamide may be considered where cost is a major barrier with close monitoring.
全部药物对比